A study that reported on HRD score of pancreatic tumors, for example, showed that the median HRD score of samples with BRCA1/BRCA2 mutations was 44, while the median HRD score of cancers with other HR related mutations was 20 [40]. The gene discussed is BRCA2; the disease is pancreatic neoplasm.